Deborah Fein is Board of Trustees Distinguished Professor Emeritus in the Department of Psychological Sciences and the Department of Pediatrics at the University of Connecticut in Storrs.
Deborah Fein
Board of Trustees Distinguished Professor Emeritus
University of Connecticut
From this contributor
‘Prototypical autism’ research is likely a dead end
Efforts to define “frank” or “classic” forms of the condition build on several assumptions that the science has not yet borne out.
‘Prototypical autism’ research is likely a dead end
By
Deborah Fein, David Amaral, Einat Waizbard-Bartov
25 January 2024 | 8 min read
Journal club: Why do some children lose their autism diagnosis?
More than one-third of a cohort of autistic toddlers no longer meet criteria for the condition at school age, according to a new study, but the findings may not generalize because the cohort is predominantly white and affluent.
Journal club: Why do some children lose their autism diagnosis?
By
Deborah Fein
9 October 2023 | 5 min read
Screening toddlers for autism is worthwhile
A Norwegian study published in February suggested that the Modified Checklist for Autism in Toddlers fails to detect many cases of autism at 18 months of age. The creators of the test explain why there’s more to the story.
Screening toddlers for autism is worthwhile
By
Deborah Fein, Diana Robins
29 April 2014 | 6 min read
Explore more from The Transmitter
Autism scientists push back on CDC’s inaccurate vaccine claims
The CDC website now falsely suggests that autism-vaccine research is still an open question, prompting distrust among researchers—some of whom anticipate “more unreliable statements coming from the junta that took over” the agency.
Autism scientists push back on CDC’s inaccurate vaccine claims
The CDC website now falsely suggests that autism-vaccine research is still an open question, prompting distrust among researchers—some of whom anticipate “more unreliable statements coming from the junta that took over” the agency.
By
The Transmitter
21 November 2025 | 6 min read
Gene replacement therapy normalizes some traits in SYNGAP1 model mice
The first published virus-based gene therapy for SYNGAP1 deletion yields benefits despite the gene’s long length and complexity.
Gene replacement therapy normalizes some traits in SYNGAP1 model mice
The first published virus-based gene therapy for SYNGAP1 deletion yields benefits despite the gene’s long length and complexity.
By
Charles Q. Choi
20 November 2025 | 5 min read
Does AI understand what it produces? Henk de Regt explores how we might assess understanding in machines and humans
Building on his philosophy of how scientists understand what they work on, de Regt is extending his approach to test understanding in machines.
Does AI understand what it produces? Henk de Regt explores how we might assess understanding in machines and humans
Building on his philosophy of how scientists understand what they work on, de Regt is extending his approach to test understanding in machines.
By
Paul Middlebrooks
19 November 2025 | 1 min read